$AKBA 8-K SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On October 21, 2026, Akebia Therapeutics, Inc. (the “Company”) received a deficiency letter (the "Notice") from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the...
14 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 7, 2026, Nicholas Grund, Senior Vice President and Chief Commercial Officer of Akebia Therapeutics, Inc. (the “Company”), notified the Company of his decision to resign his employment with the Company for personal reasons. His...
05 Aug 2026	8-K: Results of Operations and Financial Condition
30 Jun 2026	8-K: Regulation FD Disclosure; Other Events
22 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
01 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
26 Feb 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
01 Dec 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
17 Nov 2025	8-K: Entry into a Material Definitive Agreement
10 Nov 2025	8-K: Results of Operations and Financial Condition
28 Oct 2025	8-K: Regulation FD Disclosure; Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
13 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
20 Mar 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
13 Mar 2025	8-K: Results of Operations and Financial Condition
07 Feb 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

Comments